Literature DB >> 7607703

Differences in peptide-binding specificity of two ankylosing spondylitis-associated HLA-B27 subtypes.

D Fruci1, R H Butler, G Greco, P Rovero, L Pazmany, E Vigneti, R Tosi, N Tanigaki.   

Abstract

Two HLA-B27 subtypes, B*2702 and B*2705, both associated with ankylosing spondylitis, were tested for binding affinity with a panel of polyalanine model nonapeptides carrying Arg at position 2 (P2) and a series of different amino acids at position 9 (P9). The alpha chains were isolated from BTB(B*2705), C1R/B*2702 (a B*2702 transfectant cell line) and from the NW (B*2702) cell line that has a peculiar peptide presentation behavior. Peptide binding was measured by the HLA alpha chain refolding assay. The results obtained show that: 1) Peptides with basic residues (Arg and Lys) and also aliphatic (Leu) and aromatic (Phe and Tyr) peptides at P9 have a similar high affinity in the binding to B*2705; 2) B*2702 binds well to P9 aliphatic and aromatic peptides but only very weakly to P9 basic peptides. Since both B*2702 and B*2705 are associated with AS the presumed arthritogenic peptide is hypothesized to have an aromatic or aliphatic residue at position 9. Peptides with basic residues in this position would be excluded as candidates because of their low binding affinity with B*2702.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607703     DOI: 10.1007/BF00178586

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  27 in total

1.  HLA class I nucleotide sequences, 1992.

Authors:  J Zemmour; P Parham
Journal:  Hum Immunol       Date:  1992-08       Impact factor: 2.850

2.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

Review 3.  Guilt by association: HLA-B27 and ankylosing spondylitis.

Authors:  R Benjamin; P Parham
Journal:  Immunol Today       Date:  1990-04

4.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

5.  Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.

Authors:  O Rötzschke; K Falk; S Stevanović; V Gnau; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  HLA class I binding of synthetic nonamer peptides carrying major anchor residue motifs of HLA-B27 (B*2705)-binding peptides.

Authors:  D Fruci; P Rovero; R H Butler; R Sorrentino; R Tosi; N Tanigaki
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

7.  HLA-B27 binding peptides derived from the 57 kD heat shock protein of Chlamydia trachomatis: novel insights into the peptide binding rules.

Authors:  A Daser; H Urlaub; P Henklein
Journal:  Mol Immunol       Date:  1994-04       Impact factor: 4.407

8.  A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha 1 domain.

Authors:  S Y Choo; L A Fan; J A Hansen
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

9.  The peptide-binding specificity of HLA-B27 subtype (B*2705) analyzed by the use of polyalanine model peptides.

Authors:  D Fruci; G Greco; E Vigneti; N Tanigaki; R H Butler; R Tosi
Journal:  Hum Immunol       Date:  1994-09       Impact factor: 2.850

10.  Genetic modulation of antigen presentation by HLA-B27 molecules.

Authors:  L Pazmany; S Rowland-Jones; S Huet; A Hill; J Sutton; R Murray; J Brooks; A McMichael
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  1 in total

Review 1.  HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility.

Authors:  J A Lopez De Castro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.